173 related articles for article (PubMed ID: 23673449)
1. Evaluation of the mean platelet volume in secondary amyloidosis due to familial Mediterranean fever.
Ozkayar N; Piskinpasa S; Akyel F; Dede F; Yildirim T; Turgut D; Koc E; Haznedaroglu IC
Rheumatol Int; 2013 Oct; 33(10):2555-9. PubMed ID: 23673449
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Mean Platelet Volume in Patients with AA Amyloidosis and AA Amyloidosis Secondary to Familial Mediterranean Fever: A Retrospective Chart - Review Study.
Bakan A; Oral A; Alışır Ecder S; Şaşak Kuzgun G; Elçioğlu ÖC; Demirci R; Aydın Bahat K; Odabas AR
Med Sci Monit; 2019 May; 25():3854-3859. PubMed ID: 31123243
[TBL] [Abstract][Full Text] [Related]
3. Mean platelet volume in familial Mediterranean fever related AA amyloidosis and comparison with common primary glomerular diseases.
Yıldırım T; Kütahya B; İş F; Erdevir M; Üzerk Kibar M; Koç NS; Ayhan EA; Yılmaz ŞR; Erdem Y
Turk J Med Sci; 2021 Oct; 51(5):2364-2368. PubMed ID: 33984890
[TBL] [Abstract][Full Text] [Related]
4. Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever.
Sakallı H; Kal O
Clin Rheumatol; 2013 Aug; 32(8):1185-90. PubMed ID: 23592230
[TBL] [Abstract][Full Text] [Related]
5. The role of azurocidin in patients with familial Mediterranean fever and AA amyloidosis and its association with cardiovascular risk factors.
Bozaci I; Tatar E
Int Urol Nephrol; 2021 Mar; 53(3):531-538. PubMed ID: 33058037
[TBL] [Abstract][Full Text] [Related]
6. Does mean platelet volume influence the attack or attack-free period in the patients with Familial Mediterranean fever?
Sahin S; Senel S; Ataseven H; Yalcin I
Platelets; 2013; 24(4):320-3. PubMed ID: 22720903
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of mean platelet volume and neutrophil-to-lymphocyte ratio for evaluation of children with Familial Mediterranean fever.
Uluca Ü; Ece A; Şen V; Karabel D; Yel S; Güneş A; Tan I; Sabas M
Med Sci Monit; 2014 Sep; 20():1578-82. PubMed ID: 25189760
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the mean platelet volume in children with familial Mediterranean fever.
Arıca S; Ozer C; Arıca V; Karakuş A; Celik T; Güneşaçar R
Rheumatol Int; 2012 Nov; 32(11):3559-63. PubMed ID: 22086472
[TBL] [Abstract][Full Text] [Related]
9. Serum galectin-3 levels were associated with proteinuria in patients with Familial Mediterranean Fever.
Yilmaz H; Inan O; Darcin T; Bilgic MA; Akcay A
Clin Exp Nephrol; 2015 Jun; 19(3):436-42. PubMed ID: 25059227
[TBL] [Abstract][Full Text] [Related]
10. Platelet activation in patients with Familial Mediterranean Fever.
Coban E; Adanir H
Platelets; 2008 Sep; 19(6):405-8. PubMed ID: 18925507
[TBL] [Abstract][Full Text] [Related]
11. Assessment of epicardial adipose tissue thickness and the mean platelet volume in children with familial Mediterranean fever.
Uluca Ü; Demir F; Ece A; Şen V; Güneş A; Aktar F; Tan İ; Karabel D; Yazgan Ü; Sabaz MN
Ital J Pediatr; 2015 Feb; 41():15. PubMed ID: 25887962
[TBL] [Abstract][Full Text] [Related]
12. Mean platelet volume in children with familial Mediterranean fever.
Makay B; Türkyilmaz Z; Unsal E
Clin Rheumatol; 2009 Aug; 28(8):975-8. PubMed ID: 19283330
[TBL] [Abstract][Full Text] [Related]
13. Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis.
Ugurlu S; Egeli BH; Bolayirli IM; Ozdogan H
Immunol Invest; 2021 Feb; 50(2-3):273-281. PubMed ID: 32321335
[No Abstract] [Full Text] [Related]
14. Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study.
Karakurt Arıtürk Ö; Üreten K; Sarı M; Yazıhan N; Ermiş E; Ergüder İ
Anadolu Kardiyol Derg; 2013 Jun; 13(4):357-62. PubMed ID: 23531873
[TBL] [Abstract][Full Text] [Related]
15. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis.
Blank N; Hegenbart U; Dietrich S; Brune M; Beimler J; Röcken C; Müller-Tidow C; Lorenz HM; Schönland SO
Amyloid; 2018 Mar; 25(1):37-45. PubMed ID: 29364741
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever.
Ugurlu S; Hacioglu A; Adibnia Y; Hamuryudan V; Ozdogan H
Orphanet J Rare Dis; 2017 May; 12(1):105. PubMed ID: 28558744
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hematological parameters in children with FMF.
Yorulmaz A; Akbulut H; Taş SA; Tıraş M; Yahya İ; Peru H
Clin Rheumatol; 2019 Mar; 38(3):701-707. PubMed ID: 30328023
[TBL] [Abstract][Full Text] [Related]
18. Simple markers for subclinical inflammation in patients with Familial Mediterranean Fever.
Özer S; Yılmaz R; Sönmezgöz E; Karaaslan E; Taşkın S; Bütün İ; Demir O
Med Sci Monit; 2015 Jan; 21():298-303. PubMed ID: 25615955
[TBL] [Abstract][Full Text] [Related]
19. Association of FMF-related (MEFV) point mutations with secondary and FMF amyloidosis.
Atagunduz MP; Tuglular S; Kantarci G; Akoglu E; Direskeneli H
Nephron Clin Pract; 2004; 96(4):c131-5. PubMed ID: 15122067
[TBL] [Abstract][Full Text] [Related]
20. Is there a real adrenal axis dysfunction in patients with amyloidosis associated with familial Mediterranean fever?
Yılmaz G; Masatlioglu S; Yetkin DO; Demirtunç R; Boysan SN; Kaplan S; Ince N
Rheumatol Int; 2012 Nov; 32(11):3421-4. PubMed ID: 22057137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
